Skip to main content
Qurient Co., Ltd. logo

Qurient Co., Ltd. — Investor Relations & Filings

Ticker · 115180 ISIN · KR7115180002 KO Professional, scientific and technical activities
Open in API
Filings indexed 437 across all filing types
Latest filing 2023-11-08 Capital/Financing Update
Country KR South Korea
Listing KO 115180

About Qurient Co., Ltd.

http://www.qurient.com/

Qurient Co., Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for unmet medical needs. The company operates on a proprietary 'Network R&D' model, a virtual approach that manages drug development programs from early discovery through clinical phases. Its pipeline includes Adrixetinib for chronic graft-versus-host disease (cGvHD), Telacebec for the treatment of tuberculosis, and a next-generation dual-payload Antibody-Drug Conjugate (ADC) platform for oncology. Qurient advances its portfolio through global clinical trials and strategic collaborations to address critical diseases.

Recent filings

Filing Released Lang Actions
[발행조건확정]증권신고서(지분증권)
Capital/Financing Update Classification · 100% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Services Commission (금융위원회) in South Korea. It specifically details the finalization of the issuance price (발행가액확정) for a rights offering (주주우선공모) of common shares. This document is a regulatory filing required for capital raising activities, specifically updating the terms of a previously filed securities registration statement. It fits the 'Capital/Financing Update' (CAP) category as it pertains to fundraising and capital structure changes.
2023-11-08 Korean
투자설명서
Capital/Financing Update Classification · 100% confidence The document is a 'Investment Prospectus' (투자설명서) for a capital increase (rights offering) by Curient Co., Ltd. It details the number of shares, subscription periods, payment dates, and extensive risk factors associated with the investment. This document is a formal regulatory filing required for public offerings of securities, which falls under the category of capital and financing updates.
2023-11-08 Korean
[기재정정]주요사항보고서(유무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주요사항보고서(유무상증자결정)' (Report on Material Matters: Decision on Paid-in and Bonus Capital Increase). It details the specific terms, ratios, and dates for a capital increase (both paid-in and bonus shares) for the company Qurient. This falls under the category of announcements regarding new share issues or capital changes.
2023-11-08 Korean
권리락(유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement regarding a 'rights offering' (유상증자) and the resulting 'ex-rights' (권리락) date for the company Qurient. It provides specific details on the share type, reference price, and the reason for the capital change. Since it announces a change in capital structure/share issuance, it falls under the Share Issue/Capital Change category.
2023-11-08 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. It details changes in share ownership by Quad Investment Management Corp. in the company Curacle (큐리언트). This type of filing is a standard regulatory requirement for institutional investors when their shareholding crosses specific thresholds, which falls under the 'Major Shareholding Notification' category.
2023-11-03 Korean
[기재정정]주요사항보고서(유무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Qurient Co., Ltd. regarding a decision on a capital increase (both paid-in and bonus issue). It details the amendment of the subscription reference date and provides comprehensive terms for the capital increase, including share allocation ratios, pricing methods, and subscription procedures. This falls under the category of announcements regarding new share issues or capital structure changes.
2023-10-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.